Selected Recent Publications By Dr. Ulanova's Group
Opsonophagocytic activity against Streptococcus pneumoniae in Indigenous and non-Indigenous patients with severe chronic kidney disease immunized with 13-valent pneumococcal conjugate vaccine.
Ulanova M, Huska B, Dubois S, McCready WG. Opsonophagocytic activity against Streptococcus pneumoniae in Indigenous and non-Indigenous patients with severe chronic kidney disease immunized with 13-valent pneumococcal conjugate vaccine. Vaccine. 2022. doi: https://doi.org/10.1016/j.vaccine.2022.06.042.
Seroprevalence of IgG and IgM antibodies to Haemophilus influenzae type a in Canadian children.
Huska B, Kubinec C, Sadarangani M, Ulanova M. Seroprevalence of IgG and IgM antibodies to Haemophilus influenzae type a in Canadian children. Vaccine. 2022. doi: 10.1016/j.vaccine.2022.01.029.
Naturally acquired antibodies against 7 Streptococcus pneumoniae serotypes in Indigenous and non-Indigenous adults.
Gaultier G, Nix EB, Thorgrimson J, Boreham D, McCready WG, Ulanova M. Naturally acquired antibodies against 7 Streptococcus pneumoniae serotypes in Indigenous and non-Indigenous adults. PLoS One. 2022. doi: https://doi.org/10.1371/journal.pone.0267051.
Characteristics of end-stage kidney disease in a cohort of Indigenous and non-Indigenous adults in Northwestern Ontario, Canada.
Domonkos V, McCready WG, Ulanova M. Characteristics of end-stage kidney disease in a cohort of Indigenous and non-Indigenous adults in Northwestern Ontario, Canada. Applied Medical Research. 2021. doi: 10.5455/amr.20211043
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in 23-valent pneumococcal polysaccharide vaccine-naive and previously immunized adult patients with severe chronic kidney disease.
Ulanova M, Huska B, Desbiens A, Gaultier G, Domonkos V, McCready WG. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in 23-valent pneomococcal polysaccharide vaccine-naive and previously immunized adult patients with severe chronic kidney disease. Vaccine. 2020. doi: 10.1016/j.vaccine.2020.12.035.
Invasive Haemophilus influenzae serotype a disease in the Hib conjugate vaccine era: where are we going?
Ulanova, M. Invasive Haemophilus influenzae serotype a disease in the Hib conjugate vaccine era: where are we going? Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa868.
Proceedings of a workshop to discuss the epidemiology of invasive Haemophilus influenzae disease with emphasis on serotype a and b in the Americas, 2019.
Cox AD, Kuo Lee R, Ulanova M, Bruce MG, Tsang RSW. Proceeding of a workshop to discuss the epidemiology of invasive Haemophilus influenzae disease with emphasis on serotype a and b in the Americas, 2019. Vaccine. 2020. doi: 10.1016/j.vaccine.2020.12.015.
Invasive Haemophilus influenzae disease in NorthWestern Ontario First Nations Communities: Case Series.
Kubinec CJ, Kelly L, Byce S, Tsang RSW, Ulanova M. Invasive Haemophilus influenzae disease in NorthWestern Ontario First Nations Communities: Case Series. International Journal of Case Reports. 2020. doi: 10.28933/ijcr-2020-05-2805.
Supraglottitis secondary to Haemophilus influenzae serotype f infection: Case report and review of literature.
Kubinec CJ, Ulanova M. Supraglottitis secondary to Haemophilus influenzae serotype f infection: Case report and review of literature. International Journal of Case Reports. 2020. doi: 10.28933/ijcr-2019-12-1105.
Amphiphilic desmuramyl peptides for the rational design of new vaccine adjuvants: Synthesis, in vitro modulation of inflammatory response and molecular docking studies.
Kahn FA, Nasim N, Wang Y, Alhazmi A, Sanam M, Ul-Haq Z, Yalamati D, Ulanova M, Jiang JM. Amphiphilic desmuramyl peptides for the rational design of new vaccine adjuvants: Sythesis, in vitro modulation of inflammatory response and molecular docking studies. Eur J Med Chem. 2021. doi: 10.1016/j.ejmech.2020.112863.
The effect of pneumococcal immunization on total and antigen-specific B cells in patients with severe chronic kidney disease.
Gauliter GN, McCready W, Ulanova M. The effect of pneumococcal immunization on total and antigen-specific B cells in patients with severe chronic kidney disease. BMC Immunol. 2019. doi: 10.1186/s12865-019-0325-9.
Whole genome sequencing to study the phylogenetic structure of serotype a Haemophilus inlfuenzae recovered from patients in Canada.
Tsang RSW, Shuel M, Ahmad T, Hayden K, Knox N, Van Domselaar G, Hoang L, Tyrrell GJ, Minion J, Van Caeseele P, Kus JV, Ulanova M, Lefebvre B, Haldane D, Garceau R, German G, Zahariadis G, Hanley B, Kandola K, Patterson M. Whole genome sequencing to study the phylogenetic structure of serotype a Haemophilus influenzae recovered from patients in Canada. Can J Microbiol. 2020. doi: 10.1139/cjm-2019-0406.
Continuing surveillance of invasive Haemophilus influenzae disease in northwestern Ontario emphasizes the importance of serotype a and non-typeable strains as causes of serious disease: a Canadian Immunization Research Network (CIRN) Study.
Cerqueira A, Byce S, Tsang RSW, Jamieson FB, Kus JV, Ulanova M. Continuing surveillance of invasive Haemophilus influenzae disease in northwestern Ontario emphasizes the importance of sertype a and non-typeable strains as causes of serious disease: a Canadian Immunization Research Network (CIRN) study. Can J Microbiol. 2019. doi: 10.1139/cjm-2019-0210.
Natural immunity against Haemophilus influenzae type a and B-cell subpopulations in adult patients with severe chronic kidney disease.
Gauliter GN, McCready W, Ulanova M. Natural immunity against Haemophilus influenzae type a and B-cell subpopulations in adult patients with severe chronic kidney disease. Vaccine. 2019. doi: 10.1016/j.vaccine.2019.05.036
Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CINR) Clinical Trials Network (CTN) study.
Nix EB, Choi J, Anthes C, Gaultier GN, Thorgrimson J, et al. Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study. PLOS ONE 2018. 13(8): e0201282.
Epidemiology of invasive pneumococcal disease in the city of Kenora, Ontario, Canada and surrounding area (2010-2016).
Eton V, Ulanova M. Epidemiology of invasive pneumococcal disease in the city of Kenora, Ontario, Canada and surrounding area (2010-2016). JAMMI, Official Journal of the Association of Microbiology and Infectious Disease Canada. 2018. (in press).
Recurrent meningitis caused by Streptococcus pneumoniae serotype 15C associated with Wiskott-Aldrich syndrome.
Eton V, Beveridge J, Ulanova M. Recurrent meningitis caused by Streptococcus pneumoniae serotype 15C associated with Wiskott-Aldrich syndrome. JAMMI, Official Journal of the Association of Microbiology and Infectious Disease Canada. 2018; 3.2:114-117. doi: 10.3138/jammi.2017-0007.
Design, synthesis and immunological evaluation of novel amphiphilic desmuramyl peptides.
Khan F, Ulanova M, Bai B, Damayanthi, Y, Jiang Z-H. Design, synthesis and immunological evaluation of novel amphiphilic desmuramyl peptides. European Journal of Medicinal Chemistry. 2017 Sept 30; 141:26-36. doi: 10.1016/j.ejmech.2017.09.070.
Syk inhibitor R406 down-regulates inflammation in an in vitro model of Pseudomonas aeruginosa infection.
Alhazmi A, Choi J, Ulanova M. Syk inhibitor R406 down-regulates inflammation in an in vitro model of Pseudomonas aeruginosa infection. Can J Physiol Pharmacol. 2017 Oct 11. doi: 10.1139/cjpp-2017-0307.
Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015.
Eton V, Schroeter A, Kelly L, Kirlew M, Tsang RSW, Ulanova M. Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015. Int J Infect Dis. 2017 Sep 22;65:27-33.
The immunostimulatory capacity of nontypeable Haemophilus influenzae lipooligosaccharide.
Gaultier GN, Colledanchise KN, Alhazmi A, Ulanova M. The immunostimulatory capacity of nontypeable Haemophilus influenzae lipooligosaccharide. Pathogens and Immunity, 2017, 2 (1): 34-49.
Editorial: The emerging Haemophilus influenzae serotype a infection and a potential vaccine: Implementation science in action.
Barreto L, Cox D, Ulanova M, Bruce MG, Tsang RSW. Editorial: The emerging Haemophilus influenzae serotype a infection and a potential vaccine: Implementation science in action. Can Commun Dis Rep. 2017;43(5):85-88.
Developing a vaccine for Haemophilus influenzae serotype a: Proceedings of a workshop.
AD Cox, L Barreto, M Ulanova, MG Bruce, RSW Tsang on behalf of the Conference Contributors. Developing a vaccine for Haemophilus influenzae serotype a: Proceedings of a workshop. Can Commun Dis Rep. 2017;43(5):89-95.
The changing epidemiology of invasive Haemophilus influenzae disease: emergence and global presence of serotype a strains that may require a new vaccine for control.
Tsang RSW and Ulanova M. The changing epidemiology of invasive Haemophilus influenzae disease: emergence and global presence of serotype a strains that may require a new vaccine for control. Vaccine. 2017 Jul 24;35(33):4270-4275.
Paediatric meningococcemia in Northwestern Ontario, Canada: a case for publicly funded meningococcal B vaccination.
Eton V, et al. Paediatric meningococcemia in Northwestern Ontario, Canada: a case for publicly funded meningococcal B vaccination. JMM Case Rep 2016 3. doi: 10.1099/jmmcr.0.005017
Haemophilus influenzae type a as a cause of pediatric septic arthritis.
Thorgrimson J and Ulanova M. Haemophilus influenzae type a as a cause of pediatric septic arthritis. JMM Case Rep 2016 3 doi:10.1099/jmmcr.0.005064
Dynamics of naturally acquired antibody against Haemophilus influenzae type a capsular polysaccharide in a Canadian Aboriginal population.
Konini A, Nix E, Ulanova M, Moghadas SM. Dynamics of naturally acquired antibody against Haemophilus influenzae type a capsular polysaccharide in a Canadian Aboriginal population. Prev Med Rep. 2016 Jan 26;3:145-50.
Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals.
Choi J, Nix EB, Gaultier GN, Cox AD, McCready W, Ulanova M. Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals. Vaccine. 2015 Apr 15;33(16):1941-7.
Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada.
Nix EB, Williams K, Cox AD, St Michael F, Romero-Steiner S, Schmidt DS, McCready WG, Ulanova M. Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada. Emerg Infect Dis. 2015 Feb;21(2):273-9.
Hospital admission for community acquired pneumonia in a First Nations population.
Poling J, et al. Hospital admission for community acquired pneumonia in a First Nations population. Can J Rural Med. 2014 Fall; 19 (4): 135-41
A review of invasive Haemophilus influenzae disease in the Indigenous populations of North America.
Tsang RS, Bruce MG, Lem M, Barreto L, Ulanova M. A review of invasive Haemophilus influenzae disease in the Indigenous populations of North America. Epidemiol Infect. 2014 Jul;142(7):1344-54.
Activation of innate immune responses by Haemophilus influenzae lipooligosaccharide.
Choi J, Cox AD, Li J, McCready W, Ulanova M. Activation of innate immune responses by Haemophilus influenzae lipooligosaccharide. Clin Vaccine Immunol. 2014 May;21(5):769-76.
Haemophilus influenzae serotype a as a cause of serious invasive infections.
Ulanova M and, Tsang RSW. Haemophilus influenzae serotype a as a cause of serious invasive infections. Lancet Infectious Diseases 2014 Jan;14(1):70-82
Emergence of non-type b encapsulated Haemophilus influenzae as a cause of pediatric meningitis in Northwestern Ontario.
Sadeghi-Aval P, et al. Emergence of non-type b encapsulated Haemophilus influenzae as a cause of pediatric meningitis in Northwestern Ontario. Can J Infect Dis Med Microbiol 2013, 24 (1):13-16
Neglected infectious disease in Aboriginal communities: Haemophilus influenzae serotype a and Helicobacter pylori.
Ulanova M, et al. Neglected infectious disease in Aboriginal communities: Haemophilus influenzae serotype a and Helicobacter pylori. Vaccine 2012, 30: 6960-6
Invasive disease caused by Haemophilus influenzae type a in Northern Ontario First Nations communities.
Kelly L, et al. Invasive disease caused by Haemophilus influenzae type a in Northern Ontario First Nations communities. J Med Microbiol 2011, 60: 384-390
Ulanova M, Huska B, Dubois S, McCready WG. Opsonophagocytic activity against Streptococcus pneumoniae in Indigenous and non-Indigenous patients with severe chronic kidney disease immunized with 13-valent pneumococcal conjugate vaccine. Vaccine. 2022. doi: https://doi.org/10.1016/j.vaccine.2022.06.042.
Seroprevalence of IgG and IgM antibodies to Haemophilus influenzae type a in Canadian children.
Huska B, Kubinec C, Sadarangani M, Ulanova M. Seroprevalence of IgG and IgM antibodies to Haemophilus influenzae type a in Canadian children. Vaccine. 2022. doi: 10.1016/j.vaccine.2022.01.029.
Naturally acquired antibodies against 7 Streptococcus pneumoniae serotypes in Indigenous and non-Indigenous adults.
Gaultier G, Nix EB, Thorgrimson J, Boreham D, McCready WG, Ulanova M. Naturally acquired antibodies against 7 Streptococcus pneumoniae serotypes in Indigenous and non-Indigenous adults. PLoS One. 2022. doi: https://doi.org/10.1371/journal.pone.0267051.
Characteristics of end-stage kidney disease in a cohort of Indigenous and non-Indigenous adults in Northwestern Ontario, Canada.
Domonkos V, McCready WG, Ulanova M. Characteristics of end-stage kidney disease in a cohort of Indigenous and non-Indigenous adults in Northwestern Ontario, Canada. Applied Medical Research. 2021. doi: 10.5455/amr.20211043
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in 23-valent pneumococcal polysaccharide vaccine-naive and previously immunized adult patients with severe chronic kidney disease.
Ulanova M, Huska B, Desbiens A, Gaultier G, Domonkos V, McCready WG. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in 23-valent pneomococcal polysaccharide vaccine-naive and previously immunized adult patients with severe chronic kidney disease. Vaccine. 2020. doi: 10.1016/j.vaccine.2020.12.035.
Invasive Haemophilus influenzae serotype a disease in the Hib conjugate vaccine era: where are we going?
Ulanova, M. Invasive Haemophilus influenzae serotype a disease in the Hib conjugate vaccine era: where are we going? Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa868.
Proceedings of a workshop to discuss the epidemiology of invasive Haemophilus influenzae disease with emphasis on serotype a and b in the Americas, 2019.
Cox AD, Kuo Lee R, Ulanova M, Bruce MG, Tsang RSW. Proceeding of a workshop to discuss the epidemiology of invasive Haemophilus influenzae disease with emphasis on serotype a and b in the Americas, 2019. Vaccine. 2020. doi: 10.1016/j.vaccine.2020.12.015.
Invasive Haemophilus influenzae disease in NorthWestern Ontario First Nations Communities: Case Series.
Kubinec CJ, Kelly L, Byce S, Tsang RSW, Ulanova M. Invasive Haemophilus influenzae disease in NorthWestern Ontario First Nations Communities: Case Series. International Journal of Case Reports. 2020. doi: 10.28933/ijcr-2020-05-2805.
Supraglottitis secondary to Haemophilus influenzae serotype f infection: Case report and review of literature.
Kubinec CJ, Ulanova M. Supraglottitis secondary to Haemophilus influenzae serotype f infection: Case report and review of literature. International Journal of Case Reports. 2020. doi: 10.28933/ijcr-2019-12-1105.
Amphiphilic desmuramyl peptides for the rational design of new vaccine adjuvants: Synthesis, in vitro modulation of inflammatory response and molecular docking studies.
Kahn FA, Nasim N, Wang Y, Alhazmi A, Sanam M, Ul-Haq Z, Yalamati D, Ulanova M, Jiang JM. Amphiphilic desmuramyl peptides for the rational design of new vaccine adjuvants: Sythesis, in vitro modulation of inflammatory response and molecular docking studies. Eur J Med Chem. 2021. doi: 10.1016/j.ejmech.2020.112863.
The effect of pneumococcal immunization on total and antigen-specific B cells in patients with severe chronic kidney disease.
Gauliter GN, McCready W, Ulanova M. The effect of pneumococcal immunization on total and antigen-specific B cells in patients with severe chronic kidney disease. BMC Immunol. 2019. doi: 10.1186/s12865-019-0325-9.
Whole genome sequencing to study the phylogenetic structure of serotype a Haemophilus inlfuenzae recovered from patients in Canada.
Tsang RSW, Shuel M, Ahmad T, Hayden K, Knox N, Van Domselaar G, Hoang L, Tyrrell GJ, Minion J, Van Caeseele P, Kus JV, Ulanova M, Lefebvre B, Haldane D, Garceau R, German G, Zahariadis G, Hanley B, Kandola K, Patterson M. Whole genome sequencing to study the phylogenetic structure of serotype a Haemophilus influenzae recovered from patients in Canada. Can J Microbiol. 2020. doi: 10.1139/cjm-2019-0406.
Continuing surveillance of invasive Haemophilus influenzae disease in northwestern Ontario emphasizes the importance of serotype a and non-typeable strains as causes of serious disease: a Canadian Immunization Research Network (CIRN) Study.
Cerqueira A, Byce S, Tsang RSW, Jamieson FB, Kus JV, Ulanova M. Continuing surveillance of invasive Haemophilus influenzae disease in northwestern Ontario emphasizes the importance of sertype a and non-typeable strains as causes of serious disease: a Canadian Immunization Research Network (CIRN) study. Can J Microbiol. 2019. doi: 10.1139/cjm-2019-0210.
Natural immunity against Haemophilus influenzae type a and B-cell subpopulations in adult patients with severe chronic kidney disease.
Gauliter GN, McCready W, Ulanova M. Natural immunity against Haemophilus influenzae type a and B-cell subpopulations in adult patients with severe chronic kidney disease. Vaccine. 2019. doi: 10.1016/j.vaccine.2019.05.036
Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CINR) Clinical Trials Network (CTN) study.
Nix EB, Choi J, Anthes C, Gaultier GN, Thorgrimson J, et al. Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study. PLOS ONE 2018. 13(8): e0201282.
Epidemiology of invasive pneumococcal disease in the city of Kenora, Ontario, Canada and surrounding area (2010-2016).
Eton V, Ulanova M. Epidemiology of invasive pneumococcal disease in the city of Kenora, Ontario, Canada and surrounding area (2010-2016). JAMMI, Official Journal of the Association of Microbiology and Infectious Disease Canada. 2018. (in press).
Recurrent meningitis caused by Streptococcus pneumoniae serotype 15C associated with Wiskott-Aldrich syndrome.
Eton V, Beveridge J, Ulanova M. Recurrent meningitis caused by Streptococcus pneumoniae serotype 15C associated with Wiskott-Aldrich syndrome. JAMMI, Official Journal of the Association of Microbiology and Infectious Disease Canada. 2018; 3.2:114-117. doi: 10.3138/jammi.2017-0007.
Design, synthesis and immunological evaluation of novel amphiphilic desmuramyl peptides.
Khan F, Ulanova M, Bai B, Damayanthi, Y, Jiang Z-H. Design, synthesis and immunological evaluation of novel amphiphilic desmuramyl peptides. European Journal of Medicinal Chemistry. 2017 Sept 30; 141:26-36. doi: 10.1016/j.ejmech.2017.09.070.
Syk inhibitor R406 down-regulates inflammation in an in vitro model of Pseudomonas aeruginosa infection.
Alhazmi A, Choi J, Ulanova M. Syk inhibitor R406 down-regulates inflammation in an in vitro model of Pseudomonas aeruginosa infection. Can J Physiol Pharmacol. 2017 Oct 11. doi: 10.1139/cjpp-2017-0307.
Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015.
Eton V, Schroeter A, Kelly L, Kirlew M, Tsang RSW, Ulanova M. Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015. Int J Infect Dis. 2017 Sep 22;65:27-33.
The immunostimulatory capacity of nontypeable Haemophilus influenzae lipooligosaccharide.
Gaultier GN, Colledanchise KN, Alhazmi A, Ulanova M. The immunostimulatory capacity of nontypeable Haemophilus influenzae lipooligosaccharide. Pathogens and Immunity, 2017, 2 (1): 34-49.
Editorial: The emerging Haemophilus influenzae serotype a infection and a potential vaccine: Implementation science in action.
Barreto L, Cox D, Ulanova M, Bruce MG, Tsang RSW. Editorial: The emerging Haemophilus influenzae serotype a infection and a potential vaccine: Implementation science in action. Can Commun Dis Rep. 2017;43(5):85-88.
Developing a vaccine for Haemophilus influenzae serotype a: Proceedings of a workshop.
AD Cox, L Barreto, M Ulanova, MG Bruce, RSW Tsang on behalf of the Conference Contributors. Developing a vaccine for Haemophilus influenzae serotype a: Proceedings of a workshop. Can Commun Dis Rep. 2017;43(5):89-95.
The changing epidemiology of invasive Haemophilus influenzae disease: emergence and global presence of serotype a strains that may require a new vaccine for control.
Tsang RSW and Ulanova M. The changing epidemiology of invasive Haemophilus influenzae disease: emergence and global presence of serotype a strains that may require a new vaccine for control. Vaccine. 2017 Jul 24;35(33):4270-4275.
Paediatric meningococcemia in Northwestern Ontario, Canada: a case for publicly funded meningococcal B vaccination.
Eton V, et al. Paediatric meningococcemia in Northwestern Ontario, Canada: a case for publicly funded meningococcal B vaccination. JMM Case Rep 2016 3. doi: 10.1099/jmmcr.0.005017
Haemophilus influenzae type a as a cause of pediatric septic arthritis.
Thorgrimson J and Ulanova M. Haemophilus influenzae type a as a cause of pediatric septic arthritis. JMM Case Rep 2016 3 doi:10.1099/jmmcr.0.005064
Dynamics of naturally acquired antibody against Haemophilus influenzae type a capsular polysaccharide in a Canadian Aboriginal population.
Konini A, Nix E, Ulanova M, Moghadas SM. Dynamics of naturally acquired antibody against Haemophilus influenzae type a capsular polysaccharide in a Canadian Aboriginal population. Prev Med Rep. 2016 Jan 26;3:145-50.
Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals.
Choi J, Nix EB, Gaultier GN, Cox AD, McCready W, Ulanova M. Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals. Vaccine. 2015 Apr 15;33(16):1941-7.
Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada.
Nix EB, Williams K, Cox AD, St Michael F, Romero-Steiner S, Schmidt DS, McCready WG, Ulanova M. Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada. Emerg Infect Dis. 2015 Feb;21(2):273-9.
Hospital admission for community acquired pneumonia in a First Nations population.
Poling J, et al. Hospital admission for community acquired pneumonia in a First Nations population. Can J Rural Med. 2014 Fall; 19 (4): 135-41
A review of invasive Haemophilus influenzae disease in the Indigenous populations of North America.
Tsang RS, Bruce MG, Lem M, Barreto L, Ulanova M. A review of invasive Haemophilus influenzae disease in the Indigenous populations of North America. Epidemiol Infect. 2014 Jul;142(7):1344-54.
Activation of innate immune responses by Haemophilus influenzae lipooligosaccharide.
Choi J, Cox AD, Li J, McCready W, Ulanova M. Activation of innate immune responses by Haemophilus influenzae lipooligosaccharide. Clin Vaccine Immunol. 2014 May;21(5):769-76.
Haemophilus influenzae serotype a as a cause of serious invasive infections.
Ulanova M and, Tsang RSW. Haemophilus influenzae serotype a as a cause of serious invasive infections. Lancet Infectious Diseases 2014 Jan;14(1):70-82
Emergence of non-type b encapsulated Haemophilus influenzae as a cause of pediatric meningitis in Northwestern Ontario.
Sadeghi-Aval P, et al. Emergence of non-type b encapsulated Haemophilus influenzae as a cause of pediatric meningitis in Northwestern Ontario. Can J Infect Dis Med Microbiol 2013, 24 (1):13-16
Neglected infectious disease in Aboriginal communities: Haemophilus influenzae serotype a and Helicobacter pylori.
Ulanova M, et al. Neglected infectious disease in Aboriginal communities: Haemophilus influenzae serotype a and Helicobacter pylori. Vaccine 2012, 30: 6960-6
Invasive disease caused by Haemophilus influenzae type a in Northern Ontario First Nations communities.
Kelly L, et al. Invasive disease caused by Haemophilus influenzae type a in Northern Ontario First Nations communities. J Med Microbiol 2011, 60: 384-390
For additional previous papers, click here